US firm Advent to buy Sanofi's generics unit

April 17, 2018
Sanofi first announced its intention to sell Zentiva in 2015

US private equity firm Advent International has agreed to acquire Zentiva, French pharmaceutical giant Sanofi's European generics arm, for 1.9 billion euros ($2.4 billion), a statement said Tuesday.

"Advent's offer is firm, binding and fully financed," the statement from Advent and Sanofi said, adding that "the transaction is expected to close by the end of 2018".

The deal, which is still subject to regulatory approval, is one of a string of mega-mergers and acquisitions in the global pharmaceuticals sector in recent months.

Sanofi CEO Olivier Brandicourt first announced an intention to sell Zentiva in November 2015, shortly after taking the reins of the French company.

"Following a comprehensive review of strategic options for our generics unit in Europe, we have determined that transferring this business to Advent is the best option to ensure its long-term success," Brandicourt said in Tuesday's statement.

Advent said it aims to build Zentiva into a "new, independent, European generics leader".

According to Bloomberg News, should the sale go through, it would "add to the more than $15 billion in transactions that Sanofi has announced so far this year".

Sanofi took over Zentiva, which is based in Prague, in 2009.

According to its website, Zentiva traces its roots back to the 15th century Black Eagle pharmacy, one of the oldest in the Czech Republic.

Shares in Sanofi slid 0.3 percent while the Paris market was up 0.3 percent overall.

Explore further: Sanofi buys US haemophilia treatment firm for $11.6 bn (Update)

Related Stories

Sanofi buys US haemophilia treatment firm for $11.6 bn (Update)

January 22, 2018
French pharmaceutical firm Sanofi said Monday it had reached an agreement to purchase US biotech company Bioverativ, which specialises in treatments for haemophilia and rare blood disorders, for $11.6 billion.

Sanofi wins big in battle for nano-drug maker

January 29, 2018
France's Sanofi announced Monday that it had reached a deal to acquire Belgian biotech firm Ablynx that values the firm at 3.9 billion euros ($4.8 billion), beating out Danish rival Novo Nordisk for the nano-drug maker.

French pharma giant Sanofi says profits up in 2016

February 8, 2017
French pharmaceuticals giant Sanofi said Wednesday that cost-cutting measures and the strong performance of its rare diseases business drove up profits last year.

Sanofi profits hit by falling US sales of diabetes drugs

November 2, 2017
French pharmaceutical giant Sanofi on Thursday posted a drop in third-quarter earnings, hit by a decline in sales of its diabetes drugs in the United States.

Sanofi: No proof that vaccine linked to Philippines deaths

February 7, 2018
Drugmaker Sanofi insists there's no evidence of a link between the world's first dengue vaccine and children's deaths in the Philippines.

Sanofi aims for top spot in consumer health via asset swap

December 15, 2015
Sanofi said on Tuesday it hopes to take over the consumer health care unit of German peer Boehringer Ingelheim via an asset swap, making the French pharmaceutical giant the sector's world leader.

Recommended for you

Doctors prescribe opioids at high rates to those at increased overdose risk

April 24, 2018
The number of first-time prescriptions for opioid drugs has not risen since about 2010, according to UCLA researchers. However, patients taking a class of drug known to increase the risk for overdoses were likelier to receive ...

Study: Ibuprofen, acetaminophen more effective than opioids in treating dental pain

April 17, 2018
Opioids are not among the most effective—or longest lasting—options available for relief from acute dental pain, a new examination of the results from more than 460 published studies has found.

Text messaging tool may help fight opioid epidemic

April 17, 2018
A new automated text messaging service may curb opioid abuse and reduce the likelihood of relapse while also decreasing treatment costs, according to researchers at Washington University School of Medicine and Epharmix, a ...

Marijuana-based drug gets positive review from US agency

April 17, 2018
A closely watched medicine made from the marijuana plant reduces seizures in children with severe forms of epilepsy and warrants approval in the United States, health officials said Tuesday.

Post-surgical opioids can, paradoxically, lead to chronic pain

April 16, 2018
Giving opioids to animals to quell pain after surgery prolongs pain for more than three weeks and primes specialized immune cells in the spinal cord to be more reactive to pain, according to a new study by the University ...

Animal study suggests common diabetes drug may also help with nicotine withdrawal

April 5, 2018
In a mouse study, a drug that has helped millions of people around the world manage their diabetes might also help people ready to kick their nicotine habits.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.